- $2.13m
- $49.13m
- $192.35m
Brief: Zynex Submits FDA Application For Its Next Generation NMES Device
Brief: Zynex Announces Share Repurchase Program
Brief: Zynex Announces Review Of Strategic Alternatives
Zynex rises on report firm weighing options including possible sale
Brief: Zynex Weighs Strategic Options Including Possible Sale - Bloomberg News
Zynex Inc reports results for the quarter ended in September - Earnings Summary
Brief: Zynex posts Q3 EPS USD 0.1.
Zynex Inc expected to post earnings of 9 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Tesla, Alibaba, Meta
Zynex rises on $10 mln share buyback plan
Brief: Zynex Announces $10 Mln Share Repurchase Program
Brief: Zynex Inc Announces New Therapy Products
Brief: Zynex Reports Second Quarter 2023 Financial Results
Brief: Zynex Reports Second Quarter 2023 Financial Results
Zynex Inc reports results for the quarter ended in June - Earnings Summary
Zynex Inc expected to post earnings of 5 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Liminal Biosciences, Tesla, Quad/Graphics
Zynex gains on higher Q2 orders
Brief: Zynex Reports Preliminary Second Quarter 2023 Results